Legacy Launches Next-Gen Home Fertility Kit with Innovative ProteX™ Technology
Legacy's Innovation in At-Home Male Fertility Testing
Legacy, a frontrunner in male fertility solutions, has recently introduced an enhanced at-home semen collection kit featuring cutting-edge ProteX™ technology in partnership with Reproductive Solutions. This advancement aims to revolutionize the way sperm samples are collected, transported, and analyzed, ensuring a seamless experience for users.
A Leap Forward in Fertility Solutions
With an increasing number of men seeking fertility assessments from the comfort of their homes, Legacy understands the importance of providing reliable and efficient tools. The ProteX™ Semen Collection Cup has been developed to maintain optimal conditions for sperm samples, thus ensuring accuracy in results. Each kit retails for $99.95 and includes this advanced collection cup at no additional charge, marking a significant investment in patient care and convenience.
The ProteX cup is designed to safeguard sperm integrity while minimizing the risk of contamination and leakage during transportation. Specifically crafted to sustain sample quality for up to 24 hours, it alleviates many common issues associated with traditional collection methods.
Collaboration for Excellence
The collaboration with Reproductive Solutions showcases Legacy's commitment to fostering innovation in fertility care. As the demand for at-home male fertility services grows, this advanced technology is aimed to address concerns related to specimen handling and transport variability.
In addition to its practical benefits, the ProteX technology demonstrates efficiency in clinical performance, showcasing a 30% faster transit time and 11% greater motility retention than other options available on the market. This advancement not only enhances the reliability of at-home testing but also alleviates some of the anxieties associated with fertility assessments.
Clinical Validation and Impact
Legacy's partnership with research institutions has ensured that the ProteX technology is backed by rigorous clinical studies. These studies evaluate sperm motility characteristics under precisely controlled conditions, thereby validating its effectiveness and reliability. Notably, a retrospective study from Columbia University Fertility Center evaluated over 1,000 ICSI cycles using samples collected with the ProteX cup, demonstrating significant advancements in fertility treatment processes.
Looking Ahead: Expanding Access and Innovation
The introduction of the new at-home fertility kit is part of Legacy's broader strategy to refine its service offerings. As interest in fertility testing surges among clinics and military health systems, Legacy's dedication to scientific validation, operational excellence, and innovation in fertility care continues to grow.
By integrating advanced collection technology and service quality, Legacy aims to set a new benchmark in male fertility solutions. As the landscape of fertility services evolves, Legacy aspires to provide accessible and reliable solutions to men across the nation.
About Legacy
Legacy stands as a leader in male fertility healthcare in the United States, specializing in services such as semen analysis, sperm cryopreservation, and more. With a focus on quality and innovation, Legacy is dedicated to enhancing access to male reproductive health services through continued advancement in technology and patient care.